Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Denali Therapeutics (DNLI) Prepaid Assets (2017 - 2025)

Denali Therapeutics (DNLI) has disclosed Prepaid Assets for 9 consecutive years, with $32.8 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 2.1% to $32.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.8 million through Dec 2025, up 2.1% year-over-year, with the annual reading at $32.8 million for FY2025, 2.1% up from the prior year.
  • Prepaid Assets for Q4 2025 was $32.8 million at Denali Therapeutics, down from $34.4 million in the prior quarter.
  • The five-year high for Prepaid Assets was $60.7 million in Q1 2025, with the low at $15.1 million in Q3 2021.
  • Average Prepaid Assets over 5 years is $32.6 million, with a median of $32.6 million recorded in 2022.
  • The sharpest move saw Prepaid Assets skyrocketed 184.33% in 2022, then dropped 27.43% in 2023.
  • Over 5 years, Prepaid Assets stood at $30.6 million in 2021, then grew by 17.98% to $36.1 million in 2022, then dropped by 17.94% to $29.6 million in 2023, then rose by 8.37% to $32.1 million in 2024, then rose by 2.1% to $32.8 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $32.8 million, $34.4 million, and $35.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.